Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERN1 | O75460 | 10/20 | 0.57 |
| ▸ | TLR2 | O60603 | 1/20 | 0.47 |
| ▸ | TLR1 | Q15399 | 1/20 | 0.47 |
| ▸ | TLR6 | Q9Y2C9 | 1/20 | 0.47 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.46 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.43 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.43 |
| ▸ | PIM1 | P11309 | 1/20 | 0.42 |
| ▸ | PIM3 | Q86V86 | 1/20 | 0.42 |
| ▸ | P4HB | P07237 | 1/20 | 0.41 |
| ▸ | MAOB | P27338 | 1/20 | 0.41 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | THRB | P10828 | 1/20 | 0.41 |
| ▸ | BLM | P54132 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30843799 | 1.00 | ERN1 (0.57) | ERN1TLR2TLR1TLR6NFKB1 | |
| SCHEMBL29280862 | 0.88 | ERN1 (0.46) | ERN1TLR2TLR1TLR6NFKB1 | |
| SCHEMBL31587806 | 0.80 | ALOX12 (0.62) | ERN1TLR2TLR1TLR6TRIM24 | |
| SCHEMBL173039 | 0.80 | ALOX12 (0.62) | ERN1TLR2TLR1TLR6TRIM24 | |
| SCHEMBL7031301 | 0.80 | NFKB1 (0.42) | ERN1NFKB1P4HBMAOBABCG2 | |
| SCHEMBL6853771 | 0.79 | NFKB1 (0.44) | ERN1NFKB1TRIM24TRIM33PIM1 | |
| SCHEMBL22083591 | 0.79 | ERN1 (0.47) | ERN1TLR2TLR1TLR6NFKB1 | |
| SCHEMBL29417728 | 0.79 | NFKB1 (0.57) | NFKB1TRIM24TRIM33PIM1PIM3 | |
| SCHEMBL67207 | 0.79 | NFKB1 (0.57) | NFKB1TRIM24TRIM33PIM1PIM3 | |
| SCHEMBL396017 | 0.78 | CA2 (0.55) | NFKB1MEN1LMNAKMT2ATDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 124 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119661416-A | Small molecular probe and preparation method and application thereof | 上海师范大学 | 2025-03-21 | — | — | CN | claimed |
| CN-119639391-A | High-viscosity waterproof polyacrylate emulsion pressure-sensitive adhesive and preparation method and application thereof | 山东佳润新材料有限公司 | 2025-03-18 | — | — | CN | claimed |
| CN-117820164-A | Bis 3- (trifluoromethyl) salicylaldehyde 1, 4-xylylenediamine Schiff base, and preparation method and application thereof | 安徽省东超科技有限公司 | 2024-04-05 | — | — | CN | claimed |
| EP-2970267-B3 | P2X7 MODULATORS | JANSSEN PHARMACEUTICA NV (BE) | 2018-05-30 | — | — | EP | claimed |
| CN-122080106-A | Oleanolic acid acylhydrazone derivative and preparation method and application thereof | — | 2026-05-26 | — | — | CN | disclosed |
| EP-4703358-A1 | BENZO SIX-MEMBERED HETEROCYCLIC GSPT1 PROTEIN DEGRADATION AGENT AND USE THEREOF | China Pharmaceutical University (CN) | 2026-03-04 | — | — | EP | disclosed |
| CN-121592119-A | Solid luminescent material, preparation method and application thereof | 安徽省东超科技有限公司 | 2026-03-03 | — | — | CN | disclosed |
| US-20250382312-A1 | BORON CONTAINING PYRAZOLE COMPOUNDS, COMPOSITIONS COMPRISING THEM, METHODS AND USES THEREOF | BORAH INC (US) | 2025-12-18 | — | — | US | disclosed |
| EP-4370207-B1 | BICYCLIC COMPOUNDS AS ANDROGEN RECEPTOR MODULATORS | NIDO BIOSCIENCES INC (US) | 2025-12-17 | — | — | EP | disclosed |
| US-20250320201-A1 | COMPOUNDS AND METHODS USEFUL FOR STABILIZING PHENYLALANINE HYDROXYLASE MUTATIONS | AGIOS PHARMACEUTICALS INC (US) | 2025-10-16 | — | — | US | disclosed |
| US-12404286-B2 | Boron containing pyrazole compounds, compositions comprising them, methods and uses thereof | BORAH, INC. (US) | 2025-09-02 | — | — | US | disclosed |
| EP-4539855-A1 | BORON CONTAINING PYRIMIDINE COMPOUNDS, COMPOSITIONS COMPRISING THEM, METHODS AND USES THEREOF | Borah, Inc. (US) | 2025-04-23 | — | — | EP | disclosed |
| CN-1972920-A | Arylalkyl piperazine derivatives for the treatment of conditions ameliorated by monoamine reuptake including vasomotor symptoms | WYETH CORP (US) | 2007-05-30 | — | — | CN | disclosed |
| EP-1764075-A1 | TISSUE FACTOR PRODUCTION INHIBITOR | Sankyo Company, Limited (JP) | 2007-03-21 | — | — | EP | disclosed |
| EP-1692111-A2 | QUINOLINES USEFUL IN TREATING CARDIOVASCULAR DISEASE | Wyeth, A Corporation of the State of Delaware (US) | 2006-08-23 | — | — | EP | disclosed |
| WO-2005058834-A2 | QUINOLINES USEFUL IN TREATING CARDIOVASCULAR DISEASE | WYETH (US) | 2005-06-30 | — | — | WO | disclosed |
| US-20050131014-A1 | Quinolines useful in treating cardiovascular disease | WYETH (US) | 2005-06-16 | — | — | US | disclosed |
| US-6852871-B2 | Method for producing optically active salicylaldimine copper complex | SUMITOMO CHEMICAL COMPANY LIMITED (JP) | 2005-02-08 | — | — | US | disclosed |
| US-20030233003-A1 | Method for producing optically active salicylaldimine copper complex | SUMITOMO CHEMICAL COMPANY, LIMITED | 2003-12-18 | — | — | US | disclosed |
| EP-1371631-A1 | Method for producing optically active salicylaldimine copper complex | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2003-12-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030233003-A1 | Method for producing optically active salicylaldimine copper complex | ADH1A, ALDH3A1, ADH1C | ERN1 1138/4885TLR2 1719/4885TLR1 286/4885 |
| US-20250382312-A1 | BORON CONTAINING PYRAZOLE COMPOUNDS, COMPOSITIONS COMPRISING THEM, METHODS AND USES THEREOF | JAK3, JAK1, JAK2 | ERN1 1139/4885TLR2 1079/4885TLR1 443/4885 |
| US-20250320201-A1 | COMPOUNDS AND METHODS USEFUL FOR STABILIZING PHENYLALANINE HYDROXYLASE MUTATIONS | PAH, KDM8, PHF8 | ERN1 1842/4885TLR2 4777/4885TLR1 4706/4885 |
| US-12404286-B2 | Boron containing pyrazole compounds, compositions comprising them, methods and uses thereof | JAK3, JAK1, JAK2 | ERN1 1139/4885TLR2 1079/4885TLR1 443/4885 |
| US-20050131014-A1 | Quinolines useful in treating cardiovascular disease | NR1H2, NR1H3, SREBF1 | ERN1 2548/4885TLR2 923/4885TLR1 490/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.